COFACTOR GENOMICS ANNOUNCES STRATEGIC INVESTMENT BY LABCORP AND ASCENSION VENTURES TO FUEL EXPANSION OF ITS ONCOPRISM® IMMUNOTHERAPY DIAGNOSTIC ACROSS U.S. CANCER CARE NETWORKS

Reuters · 3d ago

Please log in to view news